Lucent Drugs Private Limited - Company Profile

It is a chemicals private limited company based in Sanathnagar, Telangana, India, established in 2017.
2017 Sanathnagar, Telangana, India Active
Last Updated:
Access Report
About Lucent Drugs Private Limited

Lucent Drugs Private Limited, a active private limited company, was established on 02 August 2017 in Sanathnagar, Telangana, India. Engaging in medicinal chemical & botanical products within the manufacturing sector, it holds CIN: U24100TG2017PTC118662. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹9.00 Cr and a paid-up capital of ₹6.28 Cr.

It upholds a compliant status. Employing 63 professional, Its leadership includes Sreenivasulu Devarasetty (Director), Mahaveer Chand Jain (Director). Past directors included Sai Vikas Devarasetty, Vinod Jain, Mahaveer Chand Jain. It holds ₹19.54 Cr open charges and ₹16.10 Cr settled loans. Its latest AGM occurred on 28 September 2024, with the balance sheet filed on 31 March 2024. It is based at Flat No.W-109,Svss Nivas, Oppo.Gokul Theatre Czech Colony,Street No.1, Sanathnagar, Telangana, 500018.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24100TG2017PTC118662

  • Registration Number

    118662

  • Incorporation Date

    02 August 2017

  • Authorized Capital

    ₹9.00 Cr

  • Paid-Up Capital

    ₹6.28 Cr

  • ROC Code

    Roc Hyderabad

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 9.00 Cr
  • Paid Up Capital ₹ 6.28 Cr
  • Company Age 8 Year, 7 Months
  • Last Filing with ROC 31 Mar 2024
  • Open Charges ₹ 19.54 Cr
  • Satisfied Charges ₹ 16.10 Cr
  • Revenue Growth **** -8.35%
  • Profit Growth **** -29.85%
  • Ebitda **** -18.41%
  • Net Worth 52.01%
  • Total Assets **** 54.11%
Company report

Lucent Drugs Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Lucent Drugs Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Lucent Drugs Private Limited?
Current Directors
Name Designation Appointment Date Status
Sreenivasulu Devarasetty Director 02 Aug 2017 Current
Mahaveer Chand Jain Director 14 Jun 2022 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Additional Director 30 Sep 2022 Past
Pramod Abcsdd Director 01 Apr 2019 Past
Pramod Abcsdd Additional Director 30 Sep 2022 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Lucent Drugs.

Lucent Drugs Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 8.35% decrease. The company also saw a substantial fall in profitability, with a 29.85% decrease in profit. The company's net worth Soared by an impressive increase of 52.01%.

Lucent Drugs revenue growth over time
Lucent Drugs profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 -8.35%
*******
*******
*******
*******
Revenue from Operations
*******
 -8.48%
*******
*******
*******
*******
Total Assets
*******
 54.11%
*******
*******
*******
*******
Profit or Loss
*******
 -29.85%
*******
*******
*******
*******
Net Worth
*******
 52.01%
*******
*******
*******
*******
EBITDA
*******
 -18.41%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Lucent Drugs?

In 2023, Lucent Drugs had a promoter holding of 73.63% and a public holding of 26.37%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹195,448,950.00

Satisfied Charges

₹161,000,000.00

Charges Breakdown by Lending Institutions
  • Standard Chartered Bank : 18.89 Cr
  • Hdfc Bank Limited : 0.65 Cr
Latest Charge Details
Date Lender Amount Status
21 Mar 2025 Hdfc Bank Limited ₹2.02 M Open
26 Aug 2024 Standard Chartered Bank ₹18.89 Cr Open
02 Dec 2022 Hdfc Bank Limited ₹2.33 M Open
21 Oct 2022 Hdfc Bank Limited ₹2.21 M Open
28 Mar 2018 State Bank Of India ₹16.10 Cr Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Lucent Drugs?

Lucent Drugs has a workforce of 63 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Lucent Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Lucent Drugs's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Lucent Drugs
Recent Activity within the Organization
  • Charges

    Progress on A charge with Standard Chartered Bank of Rs. 18.89 Cr registered on 26 Aug 2024 with Charge ID 100986511 was modified on 27 Jun 2025. was documented.

  • Charges

    The activity A charge registered on 28 Mar 2018 via Charge ID 100173302 with State Bank Of India was fully satisfied on 24 Mar 2025. was completed.

  • Charges

    A charge with Hdfc Bank Limited amounted to Rs. 0.20 Cr with Charge ID 101071437 was registered on 21 Mar 2025. was recorded as a recent event.

  • Annual General Meeting

    The activity Lucent Drugs Private Limited last Annual general meeting of members was held on 28 Sep 2024 as per latest MCA records. was completed.

  • Charges

    Progress on A charge with Standard Chartered Bank amounted to Rs. 18.89 Cr with Charge ID 100986511 was registered on 26 Aug 2024. was documented.

  • Balance Sheet

    The activity Lucent Drugs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Lucent Drugs Private Limited?

The CIN of Lucent Drugs Private Limited is U24100TG2017PTC118662.

Where is Lucent Drugs Private Limited headquartered?

Lucent Drugs Private Limited is headquartered at Flat No.W-109,Svss Nivas, Oppo.Gokul Theatre Czech Colony,Street No.1, Sanathnagar, Telangana, 500018.

When was Lucent Drugs Private Limited incorporated?

Lucent Drugs Private Limited was incorporated on 02 August 2017.

Who are the current directors of Lucent Drugs Private Limited?

The current directors of Lucent Drugs Private Limited are

What is the primary industry of Lucent Drugs Private Limited?

The primary industry of Lucent Drugs Private Limited is Manufacturing.

Is Lucent Drugs Private Limited a listed company?

Lucent Drugs Private Limited is unlisted.

What is the capital structure of Lucent Drugs Private Limited?

The authorized capital of Lucent Drugs Private Limited is ₹9.00 Cr, and the paid-up capital is ₹6.28 Cr.

What is the compliance status of Lucent Drugs Private Limited?

The compliance status of Lucent Drugs Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available